Compare Neurocrine Biosciences Inc (NBIX) vs Zeta Global Holdings Corp (ZETA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Zeta Global Holdings Corp — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Zeta Global Holdings Corp trades at $21.12 (market cap $5.32B). The key difference: Neurocrine Biosciences Inc is far larger — about 3.3× Zeta Global Holdings Corp's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Zeta Global Holdings Corp nearer its low. Which is the better fit depends on your goals.
| NBIX | ZETA | |
|---|---|---|
Market Cap | $17.40B | $5.32B |
Sector | Health | Technology |
52-Week High | $180.55 | $25.24 |
52-Week Low | $123.10 | $14.55 |
Enterprise Value | $16.49B | $5.23B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Zeta Global Holdings Corp
Zeta Global is a leading data-driven marketing technology company that provides an omnichannel AI Marketing Cloud. By leveraging a proprietary data cloud of over 2.4 billion deterministic identities, it enables enterprise brands to acquire, grow, and retain customers through predictive intelligence and automated, agentic workflows.
Read more on ZETA →
